Context Data on the benefits of intensive lipid-lowering treatment for elderly persons with heart disease are sparse. Contribution This secondary analysis of a trial examined outcomes of 3809 adults 65 years of age or older with coronary heart disease who were randomly assigned to receive atorvas…